HealthNet - All plan years |
Skyrizi (150 MG Dose) (risankizumab-rzaa) |
Drugs for the Skin : Drugs for the Skin |
- Step Therapy: Psoriasis (PsO):
ST Single Generic
- Prior Authorization: Psoriasis (PsO):
Documented Diagnosis: Yes
Age Requirement: >= 18
Duration: 6 Month(s)
Reauthorization Required: Yes
- Psoriasis (PsO):
Age Requirement: >= 18
Duration: 6 Month(s)
Specialist Required: Yes
Documented Diagnosis: Yes
Medical Test Required: No
Specialist Type(s): 1 of Dermatologist;Rheumatologist
Reauthorization Required: Yes
Duration of Reauthorization: = 6 month(s)
TB Test required: No
History of Plaque Psoriasis: N/A
Overall % of Body Surface For Initiation: N/A
Overall % of Body Surface For Initiation With Sensitive Areas: N/A
Psoriasis Classification: Unspecified
Sensitive Area BSA Percent override: No
|